2407 Stock Overview
Engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Gaush Meditech Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$9.23 |
| 52 Week High | HK$42.05 |
| 52 Week Low | HK$8.36 |
| Beta | -0.37 |
| 1 Month Change | -8.43% |
| 3 Month Change | 3.13% |
| 1 Year Change | -73.25% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -82.04% |
Recent News & Updates
Recent updates
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Oct 27
The Consensus EPS Estimates For Gaush Meditech Ltd (HKG:2407) Just Fell A Lot
Jul 19Here's What's Concerning About Gaush Meditech's (HKG:2407) Returns On Capital
Jul 16Gaush Meditech Ltd (HKG:2407) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
Jun 19We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Jun 03Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive
Apr 05Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)
Dec 07A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)
Aug 08Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry
Jun 01Shareholder Returns
| 2407 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 9.0% | 1.6% | 2.1% |
| 1Y | -73.2% | -17.9% | 23.7% |
Return vs Industry: 2407 underperformed the Hong Kong Medical Equipment industry which returned -17.9% over the past year.
Return vs Market: 2407 underperformed the Hong Kong Market which returned 23.7% over the past year.
Price Volatility
| 2407 volatility | |
|---|---|
| 2407 Average Weekly Movement | 9.3% |
| Medical Equipment Industry Average Movement | 6.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in HK Market | 14.0% |
| 10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 2407 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2407's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 872 | Xinwei Liu | www.gaush.com |
Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprises of proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. Gaush Meditech Ltd.
Gaush Meditech Ltd Fundamentals Summary
| 2407 fundamental statistics | |
|---|---|
| Market cap | HK$1.37b |
| Earnings (TTM) | HK$96.52m |
| Revenue (TTM) | HK$1.43b |
14.1x
P/E Ratio1.0x
P/S RatioIs 2407 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2407 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.35b |
| Cost of Revenue | CN¥720.22m |
| Gross Profit | CN¥627.35m |
| Other Expenses | CN¥536.65m |
| Earnings | CN¥90.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.61 |
| Gross Margin | 46.55% |
| Net Profit Margin | 6.73% |
| Debt/Equity Ratio | 36.5% |
How did 2407 perform over the long term?
See historical performance and comparisonDividends
11.4%
Current Dividend Yield163%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 02:21 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Gaush Meditech Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Youjue Hu | Morgan Stanley |